For queries relating to News Releases, please contact:
Dr. Sarah L. White
[+1] 212 450 1543 - Business hours, EST (GMT -5 hours)
[+1] 917 379 0398 - After hours, EST (GMT -5 hours)
Email: swhite@licr.org
News Releases
This regularly updated section reflects the diversity of interests and activities of the LICR community. It focuses on recent findings, newly published results, and other news-worthy LICR events.
January 1, 2009
New Therapeutic with Reduced Side-Effects Shows Promise for Prostate Cancer
Investigators from the Ludwig Institute for Cancer Research (LICR) Melbourne Center reported today in the journal The Prostate that a potential new reagent could treat prostate tumors with greater specificity and reduced toxicity than many currently used therapies.
November 17, 2008
LICR Research Leads to US Pharmaceutical Licensing Deal
The international Ludwig Institute for Cancer Research (LICR) announced today that one of its spin-off companies, Life Science Pharmaceuticals, has licensed its lead cancer therapy candidate to pharmaceutical company Abbott.